The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer | Signal Transduction and Targeted Therapy
CRISPR enters its first human clinical trials | Science News
Editas Wins FDA Approval for IND of CRISPR Treatment for LCA10
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics | Cancer Cell International | Full Text
The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy - ScienceDirect
News: CRISPR clinical trials overview 2020 - CRISPR Medicine
IJMS | Free Full-Text | Novel CRISPR–Cas Systems: An Updated Review of the Current Achievements, Applications, and Future Research Perspectives | HTML